RapidPulse
RapidPulse
  • Home
  • Technology
  • Team
  • News
  • Clinical Trials
  • Investors
  • Careers
  • Contact
  • More
    • Home
    • Technology
    • Team
    • News
    • Clinical Trials
    • Investors
    • Careers
    • Contact

  • Home
  • Technology
  • Team
  • News
  • Clinical Trials
  • Investors
  • Careers
  • Contact

More Complete Reperfusion with the RapidPulse™ Aspiration System

Latest Headline

May 24, 2023 - ESOC 2023 Abstract

RapidPulse Feasibility Study Results Presented at European Stroke Organization Committee Annual Meeting

"RapidPulse™ is a novel cyclic aspiration technology designed to achieve faster and better reperfusion in LVOS while significantly reducing disposable device costs. Additional larger studies are currently underway."

Continue Reading

The rate of FPE (mTICI ≥2c after one-pass) was significantly higher in the RapidPulse-cohort than in the historical cohort (69% [20/29] vs. 28%; p<0.0001).


BMJ Journals - SNIS 2022

Archives

May 24, 2023

 

RapidPulse Feasibility Study Results Presented at European Stroke Organization Committee Annual Meeting


Data from five hospitals showed FPE TICI≥2c rate was 60% with RapidPulse...only 38.5% with standard aspiration

May 24, 2023  | ESOC 2023

Continue Reading

May 31, 2023

 

RapidPulse investors extend Series A funding with $10M


The company is gearing up for FDA submission in the fourth quarter of 2023

May 31, 2023 

Continue Reading

September 13, 2022

 

RapidPulse, developer of a device for treating strokes, raises $10.5M


Its technology may double the success rate of quick clot removal leading to better patient outcomes

September 13, 2022 | Source: Steven Loeb, vatornews

Continue Reading

September 13, 2022


RapidPulse Raises Funding for Ischemic Stroke Therapies

September 13, 2022 | Source: Endovascular Today

Continue Reading

July 28, 2022


First human use cases results show RapidPulse enables doctors to get first pass effect results of TICI≥2c in 69% of cases…data presented at SNIS 2022

July 28, 2022 | Source: BMJ Journals

Continue Reading

June 28, 2021

 

Stroke device maker RapidPulse spins out of Syntheon incubator

June 28, 2021 | Source: Andrea Park, FierceBiotech

Continue Reading

June 23, 2021


RapidPulse Launches With $15 Million Series A Financing for Ischemic Stroke Therapy


Industry Veterans Join Team to Support the Development of Novel Cyclic Aspiration System for Ischemic Stroke

June 23, 2021 | Source: GlobalNewswire

Continue Reading

The RapidPulse™ System is not yet cleared for marketing by the US FDA. It is not available for commercial sale.

Copyright © 2021 RapidPulse, Inc. - All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept